- 专利标题： SUBSTITUTED DIHYDROPYRAZOLO PYRAZINE CARBOXAMIDE DERIVATIVES
-
申请号： US17055190申请日： 2019-05-10
-
公开(公告)号： US20220324865A1公开(公告)日： 2022-10-13
- 发明人: Steffen MUELLER , Rudolf SCHOHE-LOOP , Nuria ORTEGA HERNANDEZ , Frank SUESSMEIER , Eloisa JIMENEZ NUNEZ , Thomas BRUMBY , Niels LINDNER , Christoph GERDES , Elisabeth POOK , Anja BUCHMUELLER , Fabienne Zdenka GAUGAZ , Dieter LANG , Stefanie ZIMMERMANN , Alexander Helmut Michael EHRMANN , Michael GERISCH , Lutz LEHMANN , Andreas TIMMERMANN , Martina SCHAEFER , Georg SCHMIDT , Karl-Heinz SCHLEMMER , Markus FOLLMANN , Elisabeth KERSTEN , Vivian WANG , Xiang GAO , Yafeng WANG
- 申请人： Bayer Aktiengesellschaft , Bayer Pharma Aktiengesellschaft
- 申请人地址： DE Leverkusen; DE Berlin
- 专利权人： Bayer Aktiengesellschaft,Bayer Pharma Aktiengesellschaft
- 当前专利权人： Bayer Aktiengesellschaft,Bayer Pharma Aktiengesellschaft
- 当前专利权人地址： DE Leverkusen; DE Berlin
- 优先权： CNPCT/CN2018/087249 20180517
- 国际申请： PCT/EP2019/062005 WO 20190510
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; A61P7/02
摘要：
The invention relates to substituted dihydropyrazolo pyrazine carboxamide derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and diabetes, and also urogenital and ophthalmic disorders.
信息查询
